DepoMed, Inc. (DEPO) Misses Q2 on Top and Bottom
DepoMed, Inc. (NASDAQ: DEPO) reported Q2 EPS of ($0.28), $0.07 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
